JY
STTK icon

Jeff Yass’s Shattuck Labs STTK Stock Holding History

Jeff Yass’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Sell
25,176
-690,789
-96% -$4.31M ﹤0.01% 12075
2026
Q1 		$4.6M Buy
715,965
+567,538
+382% +$2.69M ﹤0.01% 4377
2025
Q4 		$542K Buy
148,427
+80,311
+118% +$192K ﹤0.01% 8588
2025
Q3 		$163K Sell
68,116
-128,212
-65% -$157K ﹤0.01% 11204
2025
Q2 		$155K Buy
196,328
+144,890
+282% +$141K ﹤0.01% 11471
2025
Q1 		$48.9K Buy
51,438
+14,986
+41% +$18.5K ﹤0.01% 11874
2024
Q4 		$44.1K Buy
36,452
+15,412
+73% +$19.1K ﹤0.01% 11729
2024
Q3 		$73.4K Buy
21,040
+7,712
+58% +$28.7K ﹤0.01% 11207
2024
Q2 		$51.4K Sell
13,328
-338,783
-96% -$2.75M ﹤0.01% 11401
2024
Q1 		$3.15M Buy
352,111
+283,421
+413% +$2.6M ﹤0.01% 4433
2023
Q4 		$490K Buy
+68,690
New +$187K ﹤0.01% 8713
2023
Q2 		– Sell
-24,683
Closed -$72.6K – 13095
2023
Q1 		$72.6K Buy
+24,683
New +$87.3K ﹤0.01% 11510
2021
Q3 		– Sell
-9,864
Closed -$286K – 13537
2021
Q2 		$286K Buy
+9,864
New +$288K ﹤0.01% 10867

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's STTK Position: Q2 2026 in Review

Jeff Yass reduced its Shattuck Labs (STTK) stake by 96% in Q2 2026, selling an estimated $4.31M and leaving 25,176 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #12075.

Jeff Yass first reported a position in STTK in Q2 2021 and has held it in 13 quarters since. The position peaked at $4.6M in Q1 2026. 99 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Jeff Yass held 25,176 shares of Shattuck Labs worth $175K as of Q2 2026.
  • Jeff Yass sold 690,789 Shattuck Labs shares in Q2 2026, an estimated $4.31M.
  • Shattuck Labs made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12075 holding.
  • Jeff Yass first reported a position in Shattuck Labs in Q2 2021 and has held it in 13 quarters since.
  • Jeff Yass's Shattuck Labs position peaked at $4.6M in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.